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ABSTRACT: The correct glycosylation of biopharmaceutical glycoproteins and their
formulations is essential for them to have the desired therapeutic effect on the patient.
It has recently been shown that Raman spectroscopy can be used to quantify the
proportion of glycosylated protein from mixtures of native and glycosylated forms of
bovine pancreatic ribonuclease (RNase). Here we show the first steps toward not only
the detection of glycosylation status but the characterization of glycans themselves
from just a few protein molecules at a time using tip-enhanced Raman scattering
(TERS). While this technique generates complex data that are very dependent on the
protein orientation, with the careful development of combined data preprocessing,
univariate and multivariate analysis techniques, we have shown that we can distinguish
between the native and glycosylated forms of RNase. Many glycoproteins contain
populations of subtly different glycoforms; therefore, with stricter orientation control,
we believe this has the potential to lead to further glycan characterization using TERS,
which would have use in biopharmaceutical synthesis and formulation research.
I t is estimated that glycoproteins account for almost two-thirds of all protein species,1 and with the level of research
and investment into protein-based therapeutic products ever
increasing,2 the accurate characterization of post-translational
modifications (PTMs) is vital for therapy. In particular,
determining glycosylation status and glycan structure is
becoming an important area of analytical science due to the
potential adverse drug reactions for incorrect formulations and
the need to have the correct protein glycoform for efficacious
therapy.
In addition to the need for protein therapeutics to maintain
the correct secondary and tertiary structure from the point of
manufacture to their intended point of interaction with the
patient, glycoproteins need to have the correct glycan attached
in the correct place in order to function as intended. Incorrect
glycosylation may result in misfolding, attenuation of efficacy as
a result of compromised sorting/directing, ligand binding,
biological activity, plasma half-life, stability, and immunoge-
nicity.3
Raman spectroscopy is an increasingly popular analytical tool
in the field of biomedicine4 and has been frequently used for
the characterization of biopharmaceuticals.5 Raman has
particular advantages in that it is nondestructive and can be
applied through a transparent window into a vessel, giving it the
potential for online use in the analysis of a dynamic system.6
Raman has been used to characterize glycoproteins in the
past,7,8 as well as Raman optical activity (ROA),9−12 including
spectral differences as a result of chemical deglycosylation.13 A
combination of Raman spectroscopy and chemometric
techniques has enabled the distinction between native and
glycosylated forms of bovine pancreatic ribonuclease (RNase)
protein, including quantification of the relative amounts of each
form from mixtures.14 The quantitative detection of glycated
hemoglobin using Raman spectroscopy has also been
demonstrated.15
Even though Raman microscopy (with a typical interrogation
diameter of 1 μm) is a confocal technique, the number of
molecules within the laser focus is still vast and the spectra
recorded are thus ensemble averages of multiple layers of
protein molecules. While the majority of these molecules may
be correctly glycosylated, if a small percentage (<5%) are not, it
is highly unlikely they would be detected.14 From a formulation
point of view, there is also no information about the specific
error in the glycosylation, for example, whether the protein is
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glycosylated in the wrong place, or whether the incorrect glycan
is attached. Lazar et al. have constructed a useful review of the
current progress in the analysis of glycoproteins and their
glycans, particularly in relation to mass spectrometry.16
However, a rapidly advancing variant of Raman spectroscopy,
tip-enhanced Raman scattering (TERS), may offer an
alternative solution. TERS, like its more widely known relation
surface-enhanced Raman scattering (SERS), exploits the
phenomenon of metals with appropriately (nano)-sized
features being able to localize regions of charge density at
their surface when illuminated by appropriate electromagnetic
radiation. These so-called surface plasmons are able to interact
constructively with the electric field component of the incident
light, resulting in an enhancement of many orders of magnitude
to the light intensity, thus like SERS significantly amplifying the
intensity of Raman scattered photons.17 While SERS uses
nanopatterned surfaces or colloids to enhance microscopic or
bulk-phase measurements,18 TERS utilizes a single nano-
particle, mounted on the end of the tip of a scanning probe
microscope, such as an atomic force microscope (AFM). The
tip is scanned across a sample and provides the spatial
resolution of AFM while collecting the vibrational structural
information of an enhanced Raman measurement.19
TERS has already been used in a number of high-resolution
biological applications, for example, in the analysis of live
bacterial cells20,21 and the investigation of individual nucleic
acid strands;22 the reader is also directed to a nice review by
Treffer et al.23 for further application areas.
In this study we set out to explore the potential of TERS to
probe protein glycosylation at a near-molecular level by
immobilizing a monolayer of protein molecules on a surface
and taking TERS measurements. The high spatial resolution of
the technique has the potential to detect subtle structural
variations that indicate incorrect glycosylation, variations that
would very likely be masked by the ensemble averaging effect of
normal Raman microscopy. Here we show the first steps
toward realizing this goal using the same simple RNase model
system that was employed with conventional Raman spectros-
copy.14 We show for the first time that TERS can be used to
distinguish successfully between glycosylated and nonglycosy-
lated proteins from the measurements of just a few molecules
within a monolayer.
■ EXPERIMENTAL SECTION
Ribonuclease A and B from bovine pancreas (lyophilized
powder), D-mannose, and N-acetyl-D-glucosamine were used as
supplied from Sigma-Aldrich Ltd. (Dorset, U.K.).
Ultraflat gold nanoplates were prepared according to the
method described by Deckert-Gaudig and Deckert.24 The
proteins were dissolved in deionized water at a concentration of
0.25 g L−1 (18.2 μM). Glass coverslips with gold nanoplate-
coated surfaces were soaked in the protein solution for 19 h to
enable the protein molecules to immobilize on the gold. The
coverslips were then removed from the solution, rinsed three
times with water, and dried under vacuum. The samples were
then ready for TERS.
TERS was conducted on an AFM-Raman system comprising
of an AFM Nanowizard I (JPK Instruments AG, Germany),
mounted on an inverted microscope (Olympus IX70, Japan).
Raman was performed at 530.9 nm on a LabRam HR (Horiba
Jobin Yvon, France). In depth TERS protocols and data
processing are detailed in the Supporting Information.
Figure 1. (a) Raw TERS spectra of RNase A from one grid with examples of cosmic rays highlighted by asterisks. (b) A typical background TERS
spectrum with peaks from the silicon tip highlighted with arrows. Also shown are examples of the (c) TERS and (d) Raman spectra of mannose
(solid line) and N-acetylglucosamine (dashed line), the sugars that make up the glycan of RNase B. The TERS spectra (c) have had the silicon
background removed. Inset shows a cartoon representation of the native form of bovine RNase drawn from atomic coordinates in the PDB (5RSA)
using PyMOL. Also shown is the glycosylation point (Asn34 residue) and the RNase B glycan. Optional mannose refers to the variation in number
and possible arrangements of mannose between the different glycoforms that occur in RNase B.
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■ RESULTS AND DISCUSSION
The RNase model proteins chosen for this work were both the
native form, RNase A, and the glycosylated form, RNase B, and
are available commercially in high purity. More importantly, as
we have measured them using Raman microscopy, we also had
a solid background model in place for comparison.14 The inset
in Figure 1 shows the structure of the protein and its associated
glycan. Raman and TERS spectra of the individual sugar
monomers are also provided in Figure 1.
Ultraflat gold nanoplates24 were chosen to immobilize the
RNase proteins for TERS analysis as they are a suitable level for
AFM measurement, are transparent to allow TERS measure-
ment through the sample, and will bind effectively to the
disulfide bridges in the RNase proteins. An example of the
typical gold nanoplate topography is shown in Figure S1. The
diameter of the nanoparticle at the end of the TERS tip is
approximately 20 nm, which means each measurement will
interrogate just a few protein molecules at a time, assuming an
RNase diameter of 3.8 nm.25,26
TERS measurements were performed as previously
described.24 At first the TERS tip was scanned through the
laser spot and positioned at the location giving the highest
reflection in the optical response image. After switching from
tip-scanner to sample-scanner mode, the topography was
scanned and an appropriate nanoplate was selected. TERS
spectra were recorded by way of grids with 1−10 nm point
separation. After each grid measurement, a reference spectrum
next to the gold plate was acquired to exclude tip
contamination. The acquisition time depended on the
enhancing ability of the respective tip and was set to 1, 5, or
10 s.
Figure 2. Following cosmic ray removal and baseline correction by the asymmetric least-squares method, (a) a typical RNase A spectrum, (b) PCA
scores plots of all of the RNase A (blue circles) and RNase B (red squares) with % explained variance in brackets and (c) PCA loadings of PC1 (solid
purple) and PC2 (dashed green). Following the above, (d−f) spectra normalized against the mean blank spectrum and (g−i) after the Si overtone
was removed by further asymmetric least-squares baseline correction (see Figure S2) and the region containing the Si fundamental set to zero. Parts
d and g are example spectra from the same measurement. Parts e and h are PCA scores plots of all of the RNase A (blue circles) and RNase B (red
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Data preprocessing is often necessary with Raman spectra so
that one can extract the useful information from the
background signal, especially when enhancement techniques
such as SERS and TERS are used to probe analytes that are
weak Raman scatterers, such as sugars,27 very low concen-
tration, or as in this case, both. This was particularly apparent
here, as the raw data from the TERS measurements were highly
variable. Even between spectra that were from the same grid,
for both the sugar monomers and the protein samples, certain
points gave no significant TERS response due to lost feedback
and among those that did, there was seemingly little
consistency from spectrum to spectrum in terms of peak
position. Variations in band position and intensity are a
common observation in TERS and can be ascribed to the small
number of molecules interacting with the tip as a result of the
technique’s high spatial resolution. The band position is
therefore much more sensitive to the specific section of the
amino sequence that interacts and the associated variations in
orientation, compared to the ensemble averaging observed in
SERS measurements.26,28−30 This variability can be clearly
observed in Figure 1a, which shows the raw spectra from just
one grid of data, and was also observed when the crystalline
glycan monomers were measured (Figure 1c).
The protein sample concentration was kept low to deposit
molecules at almost monolayer coverage onto the gold
nanoplates; the aim being to get as close as possible to looking
at just one protein molecule at a time. We might expect to see
more peaks in the TERS spectrum of a sample compared to the
Raman due to the relaxation of selection rules,31 which could
result in more allowed vibrational modes. For example, we
believe this to be why strong peaks were seen at ∼1575 cm−1 in
the TERS spectra of crystalline mannose but not in the Raman
(Figure 1c,d).
When comparing the protein samples, one of the main
regions of interest was between 800 and 1100 cm−1, where
peaks from the sugar molecules are expected but not strong
peaks from the proteins. Despite this, the variability of peak
positions within such a large data set meant it was not
immediately possible to identify individual peaks that would be
indicative of glycosylation status by visual inspection only.
Principal component analysis (PCA) was therefore used to
analyze the spectra as a whole in an attempt to extract useful
information. In order to minimize the influence of random
environmental factors on the PCA, cosmic rays (such as those
indicated by asterisks in Figure 1a) were removed and the
spectra were baseline corrected to eliminate any baseline drift
and minimize fluorescence interference. PCA was then
performed on the data and the resultant scores plots are
shown in Figure 2b,c. From these PCA scores plots of PC 1
against PC 2 (Figure 2b), there appeared to be some clustering
of spectra according to the different proteins, particularly in PC
1; while PC 2 seemed to show some variation within certain
subgroups of these clusters. When the loadings were plotted
however (Figure 2c), it was apparent that this separation,
particularly in PC 1, was mainly due to the Si fundamental peak
from the TERS tip at 520 cm−1 and not from any Raman
features associated with the protein. In fact, PCA was able to
group the samples from each respective measurement grid quite
well based mainly on the features associated with the Si tip,
revealing the subtle variation between measurement grids as a
result of the background signal, which would need to be
accounted for to gain reliable results. These data are shown in
the Supporting Information (Figure S2).
An example of the background spectrum of the gold
nanoplates is shown in Figure 1b, and it is clearly dominated
by fundamental Si−Si stretch from the silicon tip. The Si
fundamental peak was so intense that it masked any protein or
carbohydrate peaks in the same region. The Si first overtone
peak at ∼960 cm−1 appeared as a small but broad increase in
the baseline and is unfortunately located in the information-rich
part of the spectrum where we might expect to see differences
between the protein samples, with sharper sample peaks often
visible on top. This made the removal of the Si overtone
somewhat more difficult without adversely affecting the useful
peaks in the same spectral region. It was therefore important to
remove this overtone accurately, and the three different
approaches detailed below were sequentially evolved to reduce
the influence of the Si peaks on the PCA model.
The first method involved fitting Gaussians under both the Si
fundamental and first overtone peaks of each spectrum. The
center position, width, and height of each were recorded, and
the ratio of each parameter between the fundamental and
overtone features were calculated. The median value of the
ratios for each parameter was then used to plot a predicted first
overtone peak based only on the properties of the measured
fundamental peak, so as to remove the influence of any other
peaks that may occupy the same region of the spectrum as the
overtone. The median was chosen over the mean to negate the
influence of a small number of extreme outliers. The fitted
fundamental Gaussian and predicted overtone Gaussian were
then subtracted from the relevant part of each spectrum.
The predicted overtone peaks fitted the general shape of the
baseline very well (data not shown) but as there were
overlapping features either side of this background peak, it
was difficult to match up the predicted Gaussian region
accurately with the continuing spectrum, leading to the
insertion of false features. As such, the Gaussian-fitting method
was not considered reliable.
The second method used to remove the Si features was to
normalize each spectrum against the mean of the blank spectra;
that is to say, the spectra of the gold nanoplates without protein
sample present. The idea was to be able to remove the
background peaks in a way that did not destroy any analytically
useful protein information in their immediate vicinity. A typical
spectrum before and after this correction procedure is shown in
Figure 2a,d, where it can be seen that the intensity of a number
of features in the spectrum have been emphasized as a result of
this processing. The PCA plot (Figure 2e) is now completely
different to that generated previously (Figure 2b), although the
loadings plot (Figure 2f) still shows some influence from the Si
fundamental peak. This is likely caused by the position of the
same peak in the blank spectrum not matching exactly that of
the sample, as evident in Figure 2d; however, this Si
fundamental vibration is no longer the dominant feature in
PC 1 and other peaks at higher wavenumber are having greater
influence.
The final method was intended to remove the influence of
the Si fundamental from the PCA model entirely while
maintaining features in the region of the Si overtone. As
such, the region containing the Si fundamental peak was set to
zero and while there was the potential to also remove other
peaks in the same region, the complete removal of the Si peak
was considered more beneficial. An asymmetric-least-squares
(ALS) baseline correction was applied to the region containing
the overtone peak with the parameters set to fit the baseline
very closely to the original data. Because of the broad nature of
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the overtone peak, the fitted baseline follows its shape reliably
but does not fit too closely to any sharper features that appear
on top. An example of this baseline fitting is shown in Figure
S3.
The example spectrum used previously is shown following
this data processing, along with the subsequent PCA scores and
loadings plots in Figure 2g−i, respectively. Features of the
spectra are not emphasized as strongly as when they are
normalized against the blank but the core cluster of the PCA
scores plot shows a similar shape and the corresponding
loadings show that very similar parts of the spectrum are
influential; with the exception of the Si fundamental which has
of course been removed.
Despite the apparent success in minimizing the influence of
the silicon background, PCA had still not conclusively
identified regions of the spectra where differences were
observable between the two forms of the protein; as evidenced
by the lack of separation of RNase A (blue circles) and B (red
squares) in Figure 2e,h. One other area that had not been
considered thus far was the enhancement factor of the TERS
measurements. Depending on the proximity and position of the
TERS tip relative to the protein molecules whose spectra were
being observed, the magnitude of the TERS enhancement will
have been different for each measurement. This was very
apparent from the individual spectra, which differed greatly in
terms of maximum intensity and this may have inadvertently
influenced the PCA scores plots in Figure 2. Thus, after the
removal of the Si features in the TERS spectra, data were
normalized to their own total signal intensity (each spectrum
was row-normalized to 1 of its total signal).
The PCA scores and loadings following this row normal-
ization are shown in Figure S4a,b for the blank-normalized data
and in Figure S4c,d for the ALS-corrected data. The fact that
the PCA scores plots are now roughly circular in shape with no
obvious clustering indicates that this normalizing step has been
successful. However, with this bias removed, PCA did not show
any separation between the two different forms of RNase
protein, even when higher PCs were investigated (data not
shown). The fact that the explained variance for PC1 is <10%
indicates that the spectra are too variable for PCA to be useful,
with no similarities between spectra, even from features
unrelated to the glycosylation status.
With no obvious markers (Raman features/bands) identifi-
able by eye or through the use of multivariate PCA, despite
strategic processing of the data, a more general approach was
taken. In the previous work by Brewster et al. using
conventional Raman spectroscopy,14 after multivariate data
processing using multivariate supervised learning (partial least-
squares), six regions of the Raman spectra were identified that
were significant in separating the two RNase types. Therefore,
the area under the curve (AUC) of these same regions was
measured in the preprocessed TERS spectra (in this example
using the normalization against the blank method for Si peak
removal), and the results represented in a box and whisker plot
in Figure 3. In general, the glycosylated form of the protein has
a higher AUC for the regions 850−900 cm−1, 1220−1300
cm−1, 1420−1490 cm−1, and 1700−1800 cm−1 and a lower
AUC for 780−820 cm−1 and 950−1000 cm−1. Assignments for
these regions are shown in the Table S1, where it is clear that
the TERS was in agreement with protein conformational
changes rather than the detection of the sugar per se.
Figure S5 shows box and whisker plots of the AUC for other
regions of the TERS spectra that are not expected to contain
any glycan specific information.14 With the exception of the
300−780 cm−1 region that includes any artifacts from the
removal of the Si fundamental peak, the AUCs show little
difference between the two forms of the protein (the two
medians are very close as are the IQRs), indicating that we may
indeed be able to classify the proteins based on features within
the “sugar regions” of the spectra.
These six sugar regions (Figure 3, Table S1) were isolated
and PCA performed on each region individually. As illustrated
for the 950−1000 cm−1 and 1700−1800 cm−1 regions, when all
the spectra are used (Figure 4a,d, respectively), there appears to
be some separation between RNase A (blue circles) and B (red
squares). Furthermore, when the spectra that fell outside the
interquartile range of the box and whisker plot in Figure 3 were
removed (the less typical spectra), the clustering is improved
dramatically, with a complete separation between the two
protein types observed for the 950−1000 cm−1 region (Figure
4b,e). Typical representative spectra, selected from the centers
of the clusters, are shown in Figure 4c,f and the features
responsible for the separation, tentatively assigned to β-sheet/
disordered secondary structure/phenylalanine and side-chain
carbonyl vibrations, respectively, (vide infra) are also high-
lighted in yellow. In our previous experiments using Raman
spectroscopy of RNase A and RNase B, we also observed
disordered protein structure as there were differences in Amide
III vibrations that could be assigned to the disordered loops of
the RNase protein in proximity to Asn34 (the glycosylation
site) as well as differences in the Amide I which could be due to
β-structure or tertiary structure changes on protein glyco-
sylation.14
Extra peaks attributed to the glycan in the spectra of RNase B
were not definitively observed, a possible explanation for which
might be the weak scattering nature of the mannose and N-
acetylglucosamine (GlcNAc) residues. From the TERS spectra
of neat mannose and GlcNAc, it is evident that even in
Figure 3. Box and whisker plot of the area under the preprocessed
TERS spectra in the wavenumber regions indicated that showed clear
differences between the two protein glycoforms using normal Raman
spectroscopy. For each region, the shaded box and whisker represents
RNase B. In each case the blue box represents the interquartile range
(IQR), the red line the median, and the black dashed whiskers the
remaining data, with the exception of any data that lie outside the IQR
by more than 1.5 × IQR (±2.7σ), which are shown by red crosses.
Vibration assignments for the regions are given in Table S1. In this
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crystalline form these molecules do not always show highly
enhanced signals in the characteristic carbohydrate region
(900−1100 cm−1). Instead, it is thought that the distinction we
observe results from differences in the way the two forms of the
protein adsorb onto the gold substrate. More specifically that
the native form of the protein (RNase A) can adsorb in many
different orientations, but the presence of the glycan in RNase
B somewhat restricts the number of possibilities. We have used
AFM to scan the topology of the gold surface that has proteins
deposited on its surfaces, and Figure S6 indicates that there are
features of approximately 3 nm in height which would
correspond to the diameter of RNase A and RNase B proteins.
We have made previous measurement from blank gold
nanoplates and these show a roughness below 1 nm (Figure
3 in ref 24). This indicates that our TERS measurements are
likely to be generated from single protein molecules. We have
not been able to characterize the structure of the protein
monolayer on the gold, but there are four disulfide bridges
within the molecule that are able to adsorb onto the surface32 as
well as numerous side-chain functional groups. It is known that
sugar molecules do not readily interact with gold surfaces33 and
therefore both sterically and chemically, the glycan is highly
likely to direct adsorption on the gold substrate so that the
glycan itself is preferentially on top of the protein surface
(exposed to the atmosphere), thus giving it the potential to
mask at least some of the protein vibrations.
The major distinguishing feature is an extra peak in the
spectrum of RNase A in the 950−1000 cm−1 region. In this
region one might expect to observe peaks associated with the
protein β-sheet,34 disordered secondary structure,35 and
possibly shifted phenylalanine ring-breathing.36 The lack of
this feature in the glycosylated protein spectra could be due to
masking of the weakly scattering glycan if it is attributed to a β-
sheet or phenylalanine vibration, or alternatively it is possible
that due to its relatively unhindered side-chain functionality, the
native form of the protein undergoes partial unfolding upon
adsorption on the gold substrate, leading to the appearance of
an additional peak attributed to disordered secondary structure.
Unfortunately we have no data to confirm either hypothesis at
this stage.
Also as a consequence of fewer carbonyl groups from the
amino acid side-chains of RNase B being able to interact with
the gold substrate (as they are facing the wrong way) compared
to RNase A, they are more able to be “seen” by the TERS tip.
This provides a tentative explanation for the increased signal
intensity in the 1700−1800 cm−1 region for RNase B compared
to RNase A (Figure 4d−f). While the TERS intensity in this
region is generally higher for RNase B than RNase A, peaks are
still observed in some RNase A spectra in this region, as would
be expected if multiple orientations were possible: in some
cases the RNase A will have adsorbed in the preferred
orientation for RNase B purely by chance. This would also
explain why there is some overlap in the PCA plot (Figure 4e).
The crystal structure of RNase B has previously been
characterized37 and interactions between the glycan and the
amino acid side-chains were not detected, thus we do not cite
this as a possible explanation for the spectral differences
observed.
It was clear that like conventional Raman spectroscopy,
TERS does contain enough information to allow the differ-
entiation between two proteins that differ in whether they are
glycosylated or not. The data processing steps required to
obtain this useful information may be quite involved; however,
care has been taken to eliminate bias with the use of exclusively
Figure 4. Following all of the preprocessing (a) shows PCA scores of the area under the curve of 950−1000 cm−1 and (b) shows PCA scores of the
interquartile range of the same data, with RNase A shown by blue circles, RNase B shown by red squares, and % explained variance in parentheses.
Part c shows representative spectra from each group in part b with RNase A in solid blue, RNase B in dashed red, and the selected region highlighted
in yellow. Parts d−f show the same information as parts a−c, but following the ALS Si-removal preprocessing route and the area under the curve of
1700−1800 cm−1. Parts a and d comprise 643 RNase A spectra and 1116 RNase B spectra, while after selection of the spectra within the IQR (b, e)
321 and 558 spectra are retained for the RNase A and B, respectively.
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unsupervised multivariate methods, meaning at no point were
the analyses developed based on prior knowledge of the sample
groups to which the TERS data belonged to.
The aim of the experiment had been to detect directly the
glycans on the glycosylated protein molecules in order to look
for differences in the glycans themselves, but this does not
appear to have been achieved here. While it is possible that this
information is present, the high level of variability in peak
positions makes it extremely difficult to make a definitive
assignment of spectral features to the sugars in the glycans. The
TERS spectra of the crystalline mannose and GlcNAc show
that sugar bands in the 800−1100 cm−1 region are only
detected if the bands in the 1400−1600 cm−1 region are very
strongly enhanced and also that the spectra of the individual
sugar monomers are highly dependent on orientation with
respect to the tip.
We do believe this research is a valuable first step toward
demonstrating the potential of TERS to characterize glycosy-
lated proteins, given that this is the first time that anyone has
been able to use TERS to distinguish between glycosylated and
native forms of a protein without any control of protein−
surface interaction. The next step would be to apply orientation
control with the design of functionalized substrates that would
force the proteins to orientate themselves on the surface in a
reproducible way, thereby minimizing the variation in peak
position from similar vibrations. With this level of control in
place, it would become more likely that structural changes as a
result of incorrect glycosylation would be detectable.
■ CONCLUSION
We have demonstrated for the first time that TERS can be used
to distinguish between glycosylated and native forms of
proteins. This is the first step toward the goal of being able
to characterize correct glycosylation of just a few protein
molecules at a time using this powerful high spatial resolution
technique. We have shown that although TERS data of protein
samples can be very complex, carefully considered data
processing steps can reveal useful information. While TERS
does not compete with the high-throughput potential of
conventional Raman for manufacturing process monitoring and
quality control, after careful design of surface substrates to
control sample orientation, TERS has the potential for use in
glycoprotein synthesis and formulation research. This will be an
area of future work as will the utility of TERS to assess
glycosylation status on single protein molecules as this may
enable the assessment of the same protein with variable
glycosylation status (i.e., mixtures of different sugars in the
glycan on protein; for example, RNase B has a variable number




The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.anal-
chem.5b03535.
Full details of instrumentation used and TERS measure-
ment, full data analysis procedures, tentative Raman band
assignments (Table S1), as well as five figures detailing
AFM topology of gold nanoplate (Figures S1 and S6)
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(20) Neugebauer, U.; Rösch, P.; Schmitt, M.; Popp, J.; Julien, C.;
Rasmussen, A.; Budich, C.; Deckert, V. ChemPhysChem 2006, 7,
1428−1430.
(21) Neugebauer, U.; Schmid, U.; Baumann, K.; Ziebuhr, W.;




Anal. Chem. 2016, 88, 2105−2112
2111
(22) Bailo, E.; Deckert, V. Angew. Chem., Int. Ed. 2008, 47, 1658−
1661.
(23) Treffer, R.; Bohme, R.; Deckert-Gaudig, T.; Lau, K.; Tiede, S.;
Lin, X. M.; Deckert, V. Biochem. Soc. Trans. 2012, 40, 609−614.
(24) Deckert-Gaudig, T.; Deckert, V. Small 2009, 5, 432−436.
(25) Ramm, L. E.; Whitlow, M. B.; Mayer, M. M. J. Immunol. 1985,
134, 2594−2599.
(26) Deckert-Gaudig, T.; Kam̈mer, E.; Deckert, V. J. Biophotonics
2012, 5, 215−219.
(27) Walton, A. G.; Blackwell, J. Biopolymers; Academic Press:
London, 1973.
(28) Ichimura, T.; Watanabe, H.; Morita, Y.; Verma, P.; Kawata, S.;
Inouye, Y. J. Phys. Chem. C 2007, 111, 9460−9464.
(29) Treffer, R.; Lin, X.; Bailo, E.; Deckert-Gaudig, T.; Deckert, V.
Beilstein J. Nanotechnol. 2011, 2, 628−637.
(30) Kurouski, D.; Deckert-Gaudig, T.; Deckert, V.; Lednev, I. K. J.
Am. Chem. Soc. 2012, 134, 13323−13329.
(31) Berweger, S.; Raschke, M. B. J. Raman Spectrosc. 2009, 40,
1413−1419.
(32) Di Felice, R.; Selloni, A.; Molinari, E. J. Phys. Chem. B 2003, 107,
1151−1156.
(33) Stuart, D. A.; Yonzon, C. R.; Zhang, X.; Lyandres, O.; Shah, N.
C.; Glucksberg, M. R.; Walsh, J. T.; Van Duyne, R. P. Anal. Chem.
2005, 77, 4013−4019.
(34) Howell, N.; Li-Chan, E. Int. J. Food Sci. Technol. 1996, 31, 439−
451.
(35) Ashton, L.; Barron, L. D.; Hecht, L.; Hyde, J.; Blanch, E. W.
Analyst 2007, 132, 468−479.
(36) Tuma, R. J. Raman Spectrosc. 2005, 36, 307−319.




Anal. Chem. 2016, 88, 2105−2112
2112
